Implications of ACST-2 for Asymptomatic Carotid Stenosis Implications of ACST-2 for Asymptomatic Carotid Stenosis
Drs John Mandrola and Richard Bulbulia discuss the results of the ACST-2 trial comparing carotid artery stenting and carotid endarterectomy in patients not recently symptomatic.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 7, 2021 Category: Cardiology Tags: Cardiology Commentary Source Type: news

How Is a Carotid Endarterectomy Performed?
Title: How Is a Carotid Endarterectomy Performed?Category: Procedures and TestsCreated: 11/20/2020 12:00:00 AMLast Editorial Review: 11/20/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 20, 2020 Category: Cardiology Source Type: news

CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request
The Centers for Medicare and Medicaid Services is seeking comment on the following information collections: 1) Annual Medical Loss Ratio (MLR) and Rebate Calculation Report and MLR Rebate Notices; 2) Data Collection for Medicare Facilities Performing Carotid Artery Stenting with Embolic Protection in Patients at High Risk for Carotid Endarterectomy; 3) Conditions for Coverage of Suppliers of End Stage Renal Disease (ESRD) Services and Supporting Regulations; and 4) Clinical Laboratory Improvement Amendments (CLIA) Regulations. Comments are due by September 14, 2020. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - August 14, 2020 Category: Rural Health Source Type: news

CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
The Centers for Medicare and Medicaid Services is seeking comment on the following information collections: 1) National Provider Identifier (NPI) Application and Update Form and Supporting Regulations; 2) Data Collection for Medicare Facilities Performing Carotid Artery Stenting with Embolic Protection in Patients at High Risk for Carotid Endarterectomy; 3) Conditions for Coverage of Suppliers of End Stage Renal Disease (ESRD) Services and Supporting Regulations; and 4) Clinical Laboratory Improvement Amendments (CLIA) Regulations. Comments are due by August 7, 2020. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - June 8, 2020 Category: Rural Health Source Type: news

Silk Road Medical clears $109m in IPO
Silk Road Medical (NSDQ:SILK) said yesterday that it cleared just more than $109 million in its initial public offering, including a fully subscribed underwriters option. The $20-per-share flotation grossed $120 million, Sunnyvale, Calif.-based Silk Road said. The company is developing a neuroprotection and stent system called Enroute as an aid to transcarotid artery revascularization procedures. Silk Road’s estimated net proceeds of $109.1 million are earmarked for sales force expansion, new clinical trials, increasing its international footprint and potentially for acquisitions. president & CEO Erica Rogers t...
Source: Mass Device - April 9, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Featured Funding Roundup Neurological Wall Street Beat Silk Road Medical Inc. Source Type: news

UPDATE: Silk Road Medical prices $120m IPO
Updated to include comment from CEO Erica Rogers Silk Road Medical late yesterday priced its initial public offering, looking to raise approximately $120 million. The Sunnyvale, Calif.-based company said it plans to float 6 million shares of its common stock at a price of $20 per share. The offering also includes a 30-day underwriters option to purchase an additional 900,000 shares of common stock. Silk Road Medical produces the Enroute transcarotid neuroprotection and stent system, which is intended for use during the transcarotid artery revascularization procedure, or TCAR. “The Enroute system is part of the devic...
Source: Mass Device - April 4, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Vascular Wall Street Beat Silk Road Medical Inc. Source Type: news

Stroke risk can be reduced by carotid surgery or stenting
To reduce the risk of a devastating stroke, each year as many as 100,000 people in the U.S. -- and many more worldwide -- with narrowing in a carotid artery undergo preventive treatment. One procedure, known as carotid endarterectomy, is a surgical operation to remove built-up plaque in the artery of the neck. A less [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 7, 2019 Category: Databases & Libraries Source Type: news

InspireMD inks distro deal for CGuard in South Africa
InspireMD (NYSE:NSPR) said today that it inked a deal with Torque Medical to distribute its CGuard Embolic Prevention System in South Africa. The Israel-based company reported that it will begin the commercial launch for CGuard in South Africa immediately. “We are extremely pleased with the opportunity to offer CGuard EPS in the South African market. We were approached by some of our key customers in the Vascular Surgery, Interventional Neurology and Interventional Cardiology field who had learned about CGuard EPS through conferences and publications and wanted us to make it available in South Africa,” Craig G...
Source: Mass Device - January 14, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Distribution Featured Vascular Wall Street Beat InspireMD Source Type: news

InspireMD touts results of next-gen stroke prevention stent study
InspireMD (NYSE:NSPR) has released the results of a meta-analysis of four clinical studies involving dual-layered (DLS) and mesh-covered stents, including the company’s MicroNet-covered stent, the CGuard embolic prevention system. The analysis concluded that carotid artery disease patients treated with mesh-covered stents experienced a 30-day minor stroke rate of 1.25%, lower than the 30-day minor stroke rates reported in other widely cited studies, such as CREST and ACT 1, for patients treated with both carotid endarterectomy and with those treated with conventional carotid stents. CREST and ACT 1 also involved lower...
Source: Mass Device - December 24, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Cardiovascular Research & Development Stents InspireMD Terumo Source Type: news

Prior IVT and Complications of Carotid Endarterectomy Prior IVT and Complications of Carotid Endarterectomy
This study aimed to determine the optimal timing of carotid endarterectomy following intravenous thrombolysis, taking into account both stroke recurrence and CEA-related complications.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Optimal Carotid Endarterectomy Window After Stroke: 8 to 14 Days Later Optimal Carotid Endarterectomy Window After Stroke: 8 to 14 Days Later
Delaying carotid endarterectomy for a few days after a stroke is likely to yield better outcomes, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 27, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Silk Road Medical touts TCAR study data
Silk Road Medical today released results from studies of its transcarotid artery revascularization procedure, touting favorable outcomes in treating patients with carotid artery disease. Data from the studies were presented at the Society for Vascular Surgery 2018 Vascular Annual Meeting in Boston. The transcarotid artery revascularization procedure uses the Sunnyvale, Calif.-based company’s Enroute transcarotid stent and neuroprotection system, and is intended to treat blockages in the carotid artery that are at risk of causing a stroke. Results from a two-year study which compared outcomes from 1,182 patients who r...
Source: Mass Device - June 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular Silk Road Medical Inc. Source Type: news

Despite Risks, Carotid Stenting Increases in Elderly, Women Despite Risks, Carotid Stenting Increases in Elderly, Women
Despite results from the landmark CREST trial that show carotid artery stenting is riskier than carotid endarterectomy in the elderly and women, rates of the procedure have increased in both groups.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Russian study pits InspireMD ’ s CGuard device against Abbott ’ s Rx Acculink carotid stent
InspireMD (NYSE:NSPR) this week touted an independent clinical trial in Russia pitting its CGuard embolic protection device against the Rx Acculink carotid stent made by Abbott (NYSE:ABT). The 100-patient trial is designed to compare the two devices in terms of neuroprotection and clinical superiority in subjects undergoing carotid endarterectomy, the Tel Aviv-based company said. Conducted at the Scientific Research Institute of Circulation Pathology in Novosibirsk, the study is led by Dr. Andrei Karpenko. The primary endpoint is new ischemic areas in the brain 24 to 48 hours post-procedure and new lesion permanence at...
Source: Mass Device - October 12, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Stents InspireMD Stroke Source Type: news

Better Clinical Care Contributing to Fewer Carotid Surgeries Better Clinical Care Contributing to Fewer Carotid Surgeries
Medicare data show a downward trend in carotid endarterectomy and carotid artery stenting in the US, likely due to improvements in prevention and clinical management, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 21, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news